Soft drinks can be misused to give false false positive SARS-CoV-2 lateral flow device results
Oni, L.; Hawcutt, D.; Buchan, I.; Semple, M. G.
10.1101/2021.07.05.21260003 medRxivShow abstract
BackgroundThe COVID-19 pandemic created the need for very large scale, rapid testing to prevent and contain transmission of the SARS-CoV-2 virus. Lateral flow device (LFD) immunoassays meet this need by indicating the presence of SARS-CoV-2 antigen from nose/throat swab washings in 30 minutes without laboratory processing, and can be manufactured quickly at low cost. Since March 2021, UK schools have asked pupils without symptoms to test twice weekly. Pupils have posted on social media about using soft drinks to create positive results. The aim of this study was to systematically test a variety soft drinks to determine whether they can cause false "false positive" LFD results. MethodsThis study used 14 soft drinks and 4 artificial sweeteners to determine the outcome of misusing them as analyte for the Innova SARS-CoV-2 antigen rapid qualitative LFD. The pH value, sugar content and ingredients of each sample are described. The LFD results were double read and a subset was repeated using the same devices and fake analytes but differently sourced. FindingsOne sample (1/14; 7%), spring water, produced a negative result. Ten drinks (10/14; 71%) produced a positive or weakly positive result. Three samples (3/14; 21%) produced void results, mostly the fruit concentrate drinks. There was no apparent correlation between the pH value (pH 5.0 in 13/14, 93%; pH 6.5 in 1/14; 7%) or the sugar content (range 0-10.7 grams per 100mls) of the drinks and their LFD result. The 4 artificial sweeteners all produced negative results. A subset of the results was fully replicated with differently sourced materials. InterpretationSeveral soft drinks can be misused to give false positive SARS-CoV-2 LFD results. Daily LFD testing should be performed first thing in the morning, prior to the consumption of any food or drinks, and supervised where feasible. FundingThis work was self-funded by author LO and the LFD were gifted for use in this study. Research in contextO_ST_ABSEvidence before this studyC_ST_ABSO_LILateral flow devices (LFD) for SARS-CoV-2 antigen testing have been used extensively in the UK and internationally in COVID-19 pandemic responses, providing rapid testing at low cost C_LIO_LIRecent reports from young people on social media suggested soft drinks might be misused as LFD analyte and produce a seemingly positive result C_LI Added value of this studyO_LIVarious common soft drinks used as fake analyte can produce false positive SARS-CoV-2 LFD results C_LIO_LIArtificial sweeteners alone in fake analyte solution did not produce false positive results C_LI Implications of all the available evidenceO_LISoft drinks misused as analyte can produce false "false positive" SARS-CoV-2 LFD results C_LIO_LIDaily testing is best done first thing in the morning, prior to any food or drink, and under supervision where possible C_LI
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- EDTA tubes are suitable for insulin and C-peptide measurement in resource-limited settings and can be stored at room temperature for up to 24 hours 94%
- Influence of age and gender on taste function of healthy subjects 92%
- Optimization Of Dried Blood Spot Assays For Hepatitis B Virus Surface Antibody Quantification 92%
Similar papers in this journal
- Non-invasive detection of bilirubin concentrations during the first week of life in a low-resource setting along the Thailand-Myanmar border 90%
- The quantified baby: real-world use of infant sleep monitoring technologies and its impact on parent mental health and medical decision-making 89%
- Reducing Covid-19 risk in schools: a qualitative examination of staff and family views and concerns 88%
Similar papers in this journal
- Clinical diagnosis of COVID-19: a prompt, feasible, and sensitive diagnostic tool for COVID-19 based on a 1,757-patient cohort (The AndroCoV Clinical Scoring for COVID-19 diagnosis) 90%
- Administration Of Levodopa In A Parkinson’S Patient Using A Novel Oral And Maxillofacial Route – A First In Human Study 89%
- A Novel Maxillofacial Technology for Drug Administration-A Randomized Controlled Trial Using Metronidazole. 89%
Similar papers in this journal
- Perceptions on undertaking regular asymptomatic self-testing for COVID-19 using lateral flow tests: A qualitative study of university students and staff 90%
- Wearable Sensing in Eating Episode Monitoring: An Updated Systematic Review Protocol 90%
- Protocol for a prospective cohort study on the feasibility of application of nutritional ultrasound in the diagnosis and follow-up of patients with nutritional risk at hospital discharge: Study on body composition and function (DRECO) 89%
Similar papers in this journal
- The Feasibility of Studying Metabolites in PICU Multi-Organ Dysfunction Syndrome Patients Over an 8-day Course Using An Untargeted Approach 87%
- Knowledge and aptitude of early childhood, primary and/or secondary education teachers referred to first aid measures in dental trauma in the province of Seville (Spain.) 87%
- Different features of cholera in malnourished and non-malnourised children: analysis of 10-year surveillance data from a large diarrheal disease hospital in urban Bangladesh 87%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.